Cargando…
DC-HIL(+) CD14(+) HLA-DR(no/low) Cells Are a Potential Blood Marker and Therapeutic Target for Melanoma
Autores principales: | Turrentine, Jake, Chung, Jin-Sung, Nezafati, Kaveh, Tamura, Kyoichi, Harker-Murray, Amy, Huth, James, Sharma, Rohit R., Harker, David B., Ariizumi, Kiyoshi, Cruz, Ponciano D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199894/ https://www.ncbi.nlm.nih.gov/pubmed/24933321 http://dx.doi.org/10.1038/jid.2014.248 |
Ejemplares similares
-
DC-HIL-expressing Myelomonocytic Cells Are Critical Promoters of Melanoma Growth
por: Chung, Jin-Sung, et al.
Publicado: (2014) -
Detection and characterization of the S. typhimurium HilA protein
por: Rodriguez, Christine R, et al.
Publicado: (2002) -
Human NK cell development in hIL-7 and hIL-15 knockin NOD/SCID/IL2rgKO mice
por: Matsuda, Masashi, et al.
Publicado: (2019) -
HilE represses the activity of the Salmonella virulence regulator HilD via a mechanism distinct from that of intestinal long-chain fatty acids
por: Joiner, Joe D., et al.
Publicado: (2023) -
Preparation of transgenic Iranian lizard Leishmania coding HIL-12
por: Donyavi, Tahereh, et al.
Publicado: (2017)